Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?

Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation. Heart failure 2022-04, Vol.15 (4), p.e009437-e009437
1. Verfasser: Thenappan, Thenappan
Format: Artikel
Sprache:eng
Schlagworte:
Heart Failure - drug therapy
Heart Transplantation
Heart-Assist Devices
Humans
Phosphodiesterase Inhibitors
Retrospective Studies
Treatment Outcome
Ventricular Dysfunction, Right
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e009437
container_issue 4
container_start_page e009437
container_title Circulation. Heart failure
container_volume 15
creator Thenappan, Thenappan
description
doi_str_mv 10.1161/CIRCHEARTFAILURE.122.009437
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2644022384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2644022384</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2912-600ed4b694942899110aacb5b6891ffa8b1db18c102f7af4410b0cdc3ec9de9d3</originalsourceid><addsrcrecordid>eNpdkE2P0zAQhi0EYpeFv4AsceGS7vijSQwHFJUuG6kSqGq5Wo4zVsymTbEdVvvvMeqyQhxGM3r1ztdDyDsGC8ZKdr1qt6vbdbPd3TTtZr9dLxjnCwAlRfWMXDIlWSG4qp7_U1-QVzH-ACj5cqlekguxFIJXlbokbm3C-ED3Eenk6Ldhiqdh6j3GhMFksT0OvvNpCpE2Lmt0gy7R73hMwdt5NIE2MfqY6Gf85S1-oG2kbaI7f0CaJrrFNPjj3afX5IUzY8Q3j_mK7G_Wu9Vtsfn6pV01m8JyxXhRAmAvu1JJJXmtFGNgjO2WXVkr5pypO9Z3rLYMuKuMk5JBB7a3Aq3qUfXiirw_zz2F6eecv9AHHy2OozniNEfNSymBc1HLbP14ttowxRjQ6VPwBxMeNAP9B7T-H7TOoPUZdO5--7ho7g7YP_X-JZsN8my4n8bMLd6N8z0GPaAZ06CBCVHlJwuerwEJAEUO4OI3Pq6LYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2644022384</pqid></control><display><type>article</type><title>Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Thenappan, Thenappan</creator><creatorcontrib>Thenappan, Thenappan</creatorcontrib><identifier>ISSN: 1941-3297</identifier><identifier>ISSN: 1941-3289</identifier><identifier>EISSN: 1941-3297</identifier><identifier>DOI: 10.1161/CIRCHEARTFAILURE.122.009437</identifier><identifier>PMID: 35332779</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Heart Failure - drug therapy ; Heart Transplantation ; Heart-Assist Devices ; Humans ; Phosphodiesterase Inhibitors ; Retrospective Studies ; Treatment Outcome ; Ventricular Dysfunction, Right</subject><ispartof>Circulation. Heart failure, 2022-04, Vol.15 (4), p.e009437-e009437</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2912-600ed4b694942899110aacb5b6891ffa8b1db18c102f7af4410b0cdc3ec9de9d3</cites><orcidid>0000-0002-6210-0467</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3685,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35332779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thenappan, Thenappan</creatorcontrib><title>Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?</title><title>Circulation. Heart failure</title><addtitle>Circ Heart Fail</addtitle><subject>Heart Failure - drug therapy</subject><subject>Heart Transplantation</subject><subject>Heart-Assist Devices</subject><subject>Humans</subject><subject>Phosphodiesterase Inhibitors</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Ventricular Dysfunction, Right</subject><issn>1941-3297</issn><issn>1941-3289</issn><issn>1941-3297</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkE2P0zAQhi0EYpeFv4AsceGS7vijSQwHFJUuG6kSqGq5Wo4zVsymTbEdVvvvMeqyQhxGM3r1ztdDyDsGC8ZKdr1qt6vbdbPd3TTtZr9dLxjnCwAlRfWMXDIlWSG4qp7_U1-QVzH-ACj5cqlekguxFIJXlbokbm3C-ED3Eenk6Ldhiqdh6j3GhMFksT0OvvNpCpE2Lmt0gy7R73hMwdt5NIE2MfqY6Gf85S1-oG2kbaI7f0CaJrrFNPjj3afX5IUzY8Q3j_mK7G_Wu9Vtsfn6pV01m8JyxXhRAmAvu1JJJXmtFGNgjO2WXVkr5pypO9Z3rLYMuKuMk5JBB7a3Aq3qUfXiirw_zz2F6eecv9AHHy2OozniNEfNSymBc1HLbP14ttowxRjQ6VPwBxMeNAP9B7T-H7TOoPUZdO5--7ho7g7YP_X-JZsN8my4n8bMLd6N8z0GPaAZ06CBCVHlJwuerwEJAEUO4OI3Pq6LYA</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Thenappan, Thenappan</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6210-0467</orcidid></search><sort><creationdate>20220401</creationdate><title>Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?</title><author>Thenappan, Thenappan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2912-600ed4b694942899110aacb5b6891ffa8b1db18c102f7af4410b0cdc3ec9de9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Heart Failure - drug therapy</topic><topic>Heart Transplantation</topic><topic>Heart-Assist Devices</topic><topic>Humans</topic><topic>Phosphodiesterase Inhibitors</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Ventricular Dysfunction, Right</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thenappan, Thenappan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation. Heart failure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thenappan, Thenappan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?</atitle><jtitle>Circulation. Heart failure</jtitle><addtitle>Circ Heart Fail</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>15</volume><issue>4</issue><spage>e009437</spage><epage>e009437</epage><pages>e009437-e009437</pages><issn>1941-3297</issn><issn>1941-3289</issn><eissn>1941-3297</eissn><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>35332779</pmid><doi>10.1161/CIRCHEARTFAILURE.122.009437</doi><orcidid>https://orcid.org/0000-0002-6210-0467</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1941-3297
ispartof Circulation. Heart failure, 2022-04, Vol.15 (4), p.e009437-e009437
issn 1941-3297
1941-3289
1941-3297
language eng
recordid cdi_proquest_miscellaneous_2644022384
source MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals
subjects Heart Failure - drug therapy
Heart Transplantation
Heart-Assist Devices
Humans
Phosphodiesterase Inhibitors
Retrospective Studies
Treatment Outcome
Ventricular Dysfunction, Right
title Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T09%3A30%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20Use%20of%20Phosphodiesterase%20Inhibitors%20After%20Left%20Ventricular%20Assist%20Device:%20Is%20It%20Time%20to%20Rethink?&rft.jtitle=Circulation.%20Heart%20failure&rft.au=Thenappan,%20Thenappan&rft.date=2022-04-01&rft.volume=15&rft.issue=4&rft.spage=e009437&rft.epage=e009437&rft.pages=e009437-e009437&rft.issn=1941-3297&rft.eissn=1941-3297&rft_id=info:doi/10.1161/CIRCHEARTFAILURE.122.009437&rft_dat=%3Cproquest_cross%3E2644022384%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2644022384&rft_id=info:pmid/35332779&rfr_iscdi=true